We are live on ! Find out more
CGA

Crescent Grove Advisors Portfolio holdings

AUM $1.04B
1-Year Est. Return 17.78%
This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+17.78%
3 Year Est. Return
+51.16%
5 Year Est. Return
+28.04%
10 Year Est. Return
AUM
$897M
AUM Growth
+$94.2M
Cap. Flow
+$14.7M
Cap. Flow %
1.63%
Top 10 Hldgs %
42.87%
Holding
302
New
31
Increased
74
Reduced
103
Closed
18

Sector Composition

Rank Sector Weight
1 Technology 20.36%
2 Financials 13.29%
3 Industrials 8.39%
4 Energy 2.49%
5 Consumer Discretionary 1.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEEL
301
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
-5
Closed -$3.68K
CEQP
302
DELISTED
Crestwood Equity Partners LP
CEQP
-85,700
Closed -$2.51M

Similar funds

Crescent Grove Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Crescent Grove Advisors held 302 positions worth $897M, up 12% from $803M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Crescent Grove Advisors's Q4 2023 filing shows 31 new, 74 increased, 103 reduced and 18 closed positions. Its largest new stake was NCR Atleos: 1,218,078 shares worth $29.6M. The largest sale was NCR Voyix, an estimated $22.7M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.

  • Crescent Grove Advisors's largest Q4 2023 buy was NCR Atleos: 1,218,078 shares worth $29.6M.
  • Crescent Grove Advisors added most to iShares 7-10 Year Treasury Bond ETF in Q4 2023, an estimated $2.79M increase.
  • Crescent Grove Advisors's biggest Q4 2023 reduction was NCR Voyix, cutting an estimated $22.7M.
  • Crescent Grove Advisors fully exited Fiserv Inc in Q4 2023, selling an estimated $3.05M.
  • Crescent Grove Advisors's ten largest holdings make up 43% of its $897M portfolio in Q4 2023.
  • Crescent Grove Advisors opened 31 new positions and closed 18 in Q4 2023.
  • Crescent Grove Advisors's portfolio value rose 12% quarter-over-quarter to $897M.

Based on Crescent Grove Advisors's 13F filing for Q4 2023, filed 30 Jan 2024.